Patent Assignment
Reel/Frame 017996/0135
Assignment of Assignor's Interest
Recorded: 2006-07-26
Pages: 13
Assignor
MERCK FROSST CANADA AND COMPANY
Executed: 2006-07-06
Assignee
MERCK FROSST CANADA LTD.
16711 TRANS-CANADA HIGHWAY, KIRKLAND, QUEBEC, H9H 3L1, CANADA
Covered Properties
(142)
2-Substituted Quinoline Dioic Acids and Pharmaceutical Compostions
Patent:
4,851,409 →
Application:
07/011,181 →
Process for the Preparation of Hmg-Coa Reductase Inhibitors and Intermediate Compounds Employed Therein
Patent:
4,855,481 →
Application:
07/176,828 →
5-Lipoxygenase Activating Protein
Patent:
5,182,367 →
Application:
07/618,449 →
(Quinolin-2-Ylmethoxy)Indoles as Inhibitors of the Biosynthesis of Leukotrienes
Patent:
5,204,344 →
Application:
07/650,825 →
Saturated Hydroxyalkylquinoline Acids as Leukotriene Antagonists
Patent:
5,428,033 →
Application:
07/774,396 →
Fluorinated Hydroxyalkylquinoline Acids as Leukotriene Antagonists
Patent:
5,270,324 →
Application:
07/866,690 →
Amorphous (Quinolin-2-Ylmethoxy)Indole Compounds Which Have Useful Pharmaceutical Utility
Patent:
5,254,567 →
Application:
07/973,491 →
Alkanesulfonamido-1-Indanone Derivatives as Inhibitors of Cyclooxygenase
Patent:
5,409,944 →
Application:
08/030,924 →
Human Cyclooxygenase-2 Cdna and Assays for Evaluating Cyclooxygenase-2 Activity
Patent:
5,543,297 →
Application:
08/064,271 →
Heteroaryl and Haloaryl Quinoline Derivatives of Cyclopropaneacetic Acid as Leukotriene Antagonists
Patent:
5,438,141 →
Application:
08/065,734 →
Dna Encoding Prostaglandin Receptor Epi
Patent:
5,985,597 →
Application:
08/068,729 →
Dna Encoding Prostaglandin Receptor Fp
Patent:
5,869,281 →
Application:
08/083,741 →
Aza-5,5-Fused Heterocyclic Acids as Leukotriene Antagonists
Patent:
5,350,760 →
Application:
08/101,882 →
Dna Encoding Human Prostaglandin Receptor EP2
Patent:
5,605,814 →
Application:
08/115,365 →
Enteric Coated Oral Compositions Containing Bisphosphonic Acid Antihypercalcemic Agents
Patent:
5,431,920 →
Application:
08/125,372 →
Dna Encoding Prostaglandin Receptor Ip
Patent:
5,516,652 →
Application:
08/134,012 →
5-Methanesulfonamido-1-Indanones as an Inhibitor of Cyclooxygenase-2
Patent:
5,604,260 →
Application:
08/147,804 →
Peptide Sequences and Antipeptide Antisera for Detecting Human Cyclooxygenase-1 and Cyclooxygenase-2 Proteins
Patent:
5,459,239 →
Application:
08/186,364 →
Leukotriene C4 Synthase
Patent:
6,204,034 →
Application:
08/196,748 →
Dna Encoding Precursor of Interleukin-1 Beta Converting Enzyme - Related Cysteine Proteinase Iii (Ice Rel-Iii)
Patent:
5,552,536 →
Application:
08/224,930 →
Dna Encoding Precursor of Interleukin-1BETA Converting Enzyme-Related Cysteine Proteinase Ii (Icerel-Ii)
Patent:
6,110,701 →
Application:
08/225,487 →
Diaryl 5,6-Fused Heterocyclic Acids as Leukotriene Antagonists
Patent:
5,472,964 →
Application:
08/260,592 →
Bisarylcarbinol Cinnamic Acids as Inhibitors of Leukotriene Bisosynthesis
Patent:
5,527,827 →
Application:
08/329,815 →
Bisarylcarbinol Derivatives as Inhibitors of Leukotriene Biosynthesis
Patent:
5,552,437 →
Application:
08/330,036 →
Aryl Substituted 5,5 Fused Aromatic Nitrogen Compounds as Anti-Inflammatory Agents
Patent:
5,552,422 →
Application:
08/371,179 →
Indole Derivatives with Affinity for the Cannabinoid Receptor
Patent:
5,532,237 →
Application:
08/388,929 →
Peptidyl Derivatives as Inhibitors of Pro-Apoptotic Cysteine Proteinases
Patent:
5,798,442 →
Application:
08/426,547 →
N-Benzylindol-3-Yl Propanoic Acid Derivatives as Cyclooxygenase Inhibitors
Patent:
5,604,253 →
Application:
08/445,624 →
N-Benzyl-3-Indoleacetic Acids as Antiinflammatory Drugs
Patent:
5,510,368 →
Application:
08/445,625 →
Human Prostaglandin Receptor Ip
Patent:
5,728,808 →
Application:
08/520,519 →
Prostaglanin Receptor EP2
Patent:
5,759,789 →
Application:
08/586,897 →
Diphenyl-1,2-3-Thiadiazoles as Anti-Inflammatory Agents
Patent:
5,677,318 →
Application:
08/678,274 →
Dna Encoding Precursor or Interleukin-1B Converting Enzyme-Related Cysteine Proteinase Iii (Icerel-Iii)
Patent:
5,760,180 →
Application:
08/721,985 →
Dna Encoding Precursor of Interleukin-1B Converting Enzyme-Related Cysteine Proteinase Ii (Icerel-Ii)
Patent:
6,103,513 →
Application:
08/721,986 →
Diphenyl Pyridyl Ethane Derivatives as Pde Iv Inhibitors
Patent:
5,710,160 →
Application:
08/763,565 →
Tri-Aryl Ethane Derivatives as Pde Iv Inhibitors
Patent:
5,710,170 →
Application:
08/763,566 →
Alkylated Styrenes as Prodrugs to Cox-2 Inhibitors
Patent:
5,789,413 →
Application:
08/786,517 →
Diaryl Bicyclic Heterocycles as Inhibitors of Cyclooxygenase-2
Patent:
6,329,421 →
Application:
08/793,931 →
Method for Identifying Inhibitors for Apopain Based Upon the Crystal Structure of the Apopain:Ac-Devd-Cho Complex
Patent:
5,834,228 →
Application:
08/800,007 →
Dna Encoding Prostaglandin Receptor Dp
Patent:
5,958,723 →
Application:
08/812,203 →
Bisaryl Cyclobutenes Derivatives as Cyclooxygenase Inhibitors
Patent:
5,817,700 →
Application:
08/814,388 →
Pyridinyl-2-Cyclopenten-1-Ones as Selective Cyclooxygenase-2 Inhibitors
Patent:
5,922,742 →
Application:
08/832,407 →
5-Methanesulfonamido-3H-Isobenzofuran-1-Ones as Inhibitors of Cyclooxygenase-2
Patent:
5,968,958 →
Application:
08/860,266 →
High Level Expression of Human Cyclooxygenase-2
Patent:
6,107,087 →
Application:
08/930,589 →
New Ligands for Phosphatase Binding Assay
Patent:
6,066,715 →
Application:
08/964,308 →
Purified Prostaglandin Receptor Fp
Patent:
5,840,847 →
Application:
08/976,074 →
Methods of Identifying Modulators of a Prostaglandin Receptor
Patent:
6,358,694 →
Application:
08/976,166 →
System for Stably Expressing a High-Affinity Camp Phosphodiesterase and Use Thereof
Patent:
5,922,557 →
Application:
09/003,626 →
Diaryl-2-(5H)-Furanones as Cox-2 Inhibitors
Patent:
6,222,048 →
Application:
09/011,674 →
Methods of Identifying Modulators of Human Prostaglandin Receptor Ip
Patent:
6,365,360 →
Application:
09/039,798 →
(Methylsulfonyl)Phenyl-2-(5H)-Furanones with Oxygen Link as Cox-2 Inhibitors
Patent:
6,071,954 →
Application:
09/042,168 →
Method for Measuring Metaplastic Changes of Mucus Secreting Epithelial Cells
Patent:
5,932,481 →
Application:
09/046,085 →
Methylsulfonyl Phenyl-2-(5H)-Furanones as Cox-2 Inhibitors
Patent:
5,981,576 →
Application:
09/097,537 →
(Methylsulfonyl)Phenyl-2(5H)-Furanones as Cox-2 Inhibitors
Patent:
6,020,343 →
Application:
09/097,543 →
Alkylated Styrenes as Prodrugs to Cox-2 Inhibitors
Patent:
5,925,631 →
Application:
09/128,140 →
2,3,5-Trisubstituted Pyridines as Inhibitors of Cyclooxygenase-2
Patent:
6,046,217 →
Application:
09/151,626 →
2-Aminopyridines as Inhibitors of Cyclooxygenase-2
Patent:
6,004,950 →
Application:
09/151,633 →
Aryl Furan Derivatives as Pde Iv Inhibitors
Patent:
6,020,339 →
Application:
09/163,032 →
Aryl Thiophene Derivatives as Pde Iv Inhibitors
Patent:
6,034,089 →
Application:
09/163,033 →
Diaryl-5-Alkyl-5-Methyl-2-(5H)-Furanones as Selective Cyclooxygenase-2-Inhibitors
Patent:
6,133,292 →
Application:
09/174,048 →
Bisaryl Cox-2 Inhibiting Compounds, Compositions and Methods of Use
Patent:
5,994,379 →
Application:
09/246,925 →
Purified Prostaglandin Receptor EP1
Patent:
6,031,079 →
Application:
09/255,671 →
Carboxylic Acids and Acylsulfonamides, Compositions Containing Such Compounds and Methods of Treatment
Patent:
6,242,493 →
Application:
09/266,047 →
Methods of Identifying Modulators of Prostaglandin Receptor EP1
Patent:
6,440,680 →
Application:
09/395,366 →
Phosphonic Acids Derivatives as Inhibitors of Protein Tyrosine Phosphate 1B (Ptp-1B)
Patent:
6,174,874 →
Application:
09/398,356 →
Biphenylene Lactams Prostaglandin Receptor Ligands
Patent:
6,277,839 →
Application:
09/410,583 →
Prostaglandin Receptor Ligands
Patent:
6,211,197 →
Application:
09/411,505 →
Methods for Inhibiting Bone Resorption
Prostaglandin Conjugates for Treating or Preventing Bone Disease
Patent:
6,121,253 →
Application:
09/440,351 →
Gamma-ketoacid tetrapeptides as inhibitors of caspase-3
Patent:
6,552,168 →
Application:
09/453,201 →
Synthesis Of 4-[5-Substituted Or Unsubstituted Phenyl)-3-Substituted-1H-Pyrazol-l-YL]Benzenesulfonamides
Patent:
6,150,534 →
Application:
09/483,564 →
Assay for emetic activity
Patent:
6,316,434 →
Application:
09/512,513 →
PDE IV Inhibiting compounds, compositions and methods of treatment
Patent:
6,204,275 →
Application:
09/513,149 →
Intact cell assay for protein tyrosine phosphatases using recombinant baculoviruses
Patent:
6,329,137 →
Application:
09/519,773 →
Heterosubstituted pyridine derivatives as PDE4 inhibitors
Patent:
6,200,993 →
Application:
09/551,040 →
Heterosubstituted pyridine derivatives as PDE 4 inhibitors
Patent:
6,316,472 →
Application:
09/551,046 →
Whole Cell Assay for Cathepsin K Activity
Patent:
6,346,373 →
Application:
09/553,724 →
Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use
Patent:
6,211,210 →
Application:
09/561,565 →
Phosphonic and carboxylic acid derivatives as inhibitors of protein tyrosine phosphatase-1b (ptp-1b)
Patent:
6,365,592 →
Application:
09/570,092 →
Methods of Identifying Modulators of Prostaglandin Receptor Dp
Patent:
6,395,499 →
Application:
09/598,418 →
High Level expression of human cyclooxygenase-2
Patent:
6,362,327 →
Application:
09/599,781 →
Pyrazinones, Compositions Containing Such Compounds and Methods of Use
Patent:
6,444,811 →
Application:
09/618,875 →
Synthesis of 4-[5-substituted or unsubstituted phenyl)-3-substituted-1H-pyrazol-1-yl] benzenesulfonamides
Patent:
6,232,472 →
Application:
09/660,685 →
Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
Patent:
6,369,084 →
Application:
09/662,234 →
Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
Patent:
6,369,082 →
Application:
09/662,502 →
Polymorphic, Amorphous and Hydrated Forms of 5-Chloro-3-(4-Methanesulfonylphenyl)-6'- Methyl-[2,3']Bipyridinyl
Patent:
6,441,002 →
Application:
09/724,522 →
Substituted 8-Arylquinoline Phosphodiesterase-4 Inhibitors
Protein Tyrosine Phosphatase-1B (Ptp-1B) Deficient Mice and Uses Thereof
Patent:
6,605,753 →
Application:
09/744,383 →
Phosphonic Acid Biaryl Derivatives as Inhibitors of Protein Tyrosine Phosphatase 1B (Ptp-1B)
Phosphonic Acid Derivatives as Inhibitors of Protein Tyrosine Phosphatase 1B (Ptp-1B)
Protein Tyrosine Phosphatase 1B (Ptp-1B) Inhibitors Containing Two Ortho-Substituted Aromatic Phosphonates
Phosphonic Acid Derivatives as Inhibitors of Protein Tyrosine Phosphatase Ib (Ptp-Ib)
Novel Compounds and Compositions as Protease Inhibitors
Process for Making 2, 5-Substituted Pyridine
Pde Iv Inhibiting Amides, Compositions and Methods of Treatment
Tri-Aryl-Substituted-Ethane PDE4 Inhibitors
Aryldifluoromethylphosphonic Acids with Sulfur-Containing Substituents as Ptp-1B Inhibitors
Aryldifluoromethylphosphonic Acids with Sulfur-Containing Substituents as Ptp-1B Inhibitors
Methods for Inhibiting Bone Resorption
Method of Treatment Using Phenyl and Biaryl Derivatives as Prostaglandin E Inhibitors and Compounds Useful Therefore
Fluoroalkoxy-Substituted Benzamide Dichloropyridinyl N-Oxide PDE4 Inhibitor
Pyrones as Inhibitors of Cyclooxygenase-2
Cyclopentanoindoles, Compositions Containing Such Compounds and Methods of Treatment
Patent:
6,410,583 →
Application:
09/909,636 →
Method for Treating or Preventing Emesis
Gamma-Ketoacid Dipeptides as Inhibitors of Caspase-3
High Level Expression of Human Cyclooxygenase-2
Substituted 8-Arylquinoline Phosphodiesterase-4 Inhibitors
Tri-Aryl-Substituted-Ethane PDE4 Inhibitors
Tri-Aryl-Substituted-Ethane PDE4 Inhibitors
1-Biaryl-1,8-Naphthyridin-4-One Phosphodiesterase-4 Inhibitors
Protein Tyrosine Phosphatase 1B (Ptp-1B) Inhibitors Containing Two Ortho-Substituted Aromatic Phosphonates
Pyrazinones, Compositions Containing Such Compounds and Methods of Use
Cathepsin Cysteine Protease Inhibitors
Alkyne-Aryl Phosphodiesterase-4 Inhibitors
Protein tyrosine phosphatase-1B (PTP-1B) deficient mice and uses thereof
Application:
10/460,115 →
Publication:
US 2003/0217379
Cathepsin Cysteine Protease Inhibitors
Dihydropyrrolo[1,2-A]Indole and Tetrahydropyrido[1,2-a]-Indole Derivatives as Prostaglandin D2 Receptor Antagonists
Substituted 8-Arylquinolune PDE4 Inhibitors
Eosinophil prostaglandin d2 receptor assays
Application:
10/483,914 →
Publication:
US 2004/0185509
Alkyne-aryl phosphodiesterase-4 inhibitors
Application:
10/487,047 →
Publication:
US 2005/0070569
Ep4 receptor agonist, compositions and methods thereof
Application:
10/493,649 →
Publication:
US 2004/0204590
Method for treating ocular hypertension
Application:
10/494,775 →
Publication:
US 2004/0254230
Cyanoalkylamino Derivatives as Protease Inhibitors
Quinolinones as Prostaglandin Receptor Ligands
Fluoro Substituted Cycloalkanoindoles, Compositions Containing Such Compounds and Methods of Treatment
Cathepsin Cysteine Protease Inhibitors
Ep4 receptor agonist, compositions and methods thereof
Application:
10/511,736 →
Publication:
US 2005/0239872
Ep4 receptor agonist, compositions and methods thereof
Application:
10/511,737 →
Publication:
US 2006/0258726
Oxazolidin-2-One and Thiazolidin-2-One Derivatives for Use as EP4 Receptor Agonists in the Treatment of Glaucoma
Cathepsin Cysteine Protease Inhibitors
Treatment of rheumatoid arthritis by inhibition of pde4
Application:
10/526,346 →
Publication:
US 2006/0019932
Ep4 receptor agonists
Application:
10/528,419 →
Publication:
US 2006/0167081
Nitric oxide releasing selective cyclooxygenase-2 inhibitors
Application:
10/530,214 →
Publication:
US 2006/0058363
Cathepsin cysteine protease inhibitors
Application:
10/530,250 →
Publication:
US 2006/0166966
Pyridopyrrolizine and Pyridoindolizine Derivatives
4-Oxo-1-3-Substituted Phenyl-1,4-Dihydro-1,8-Naphthyridine-3-Carboxamide Phosphodiesterase-4 Inhibitors
Use of phosphodiesterase-4 inhibitors as enhancers of cognition
Application:
10/536,250 →
Publication:
US 2006/0040981
Cycloalkanepyrrolopyridines as dp receptor antagonists
Application:
10/558,909 →
Publication:
US 2007/0027171
Cathepsin Cysteine Protease Inhibitors
4-Oxo-1-(3-Substituted Phenyl-1,4-Dihydro-1,8-Naphthyridine-3-Carboxamide Phosphodiesterase-4 Inhibitors
EP4 Receptor Agonist, Compositions and Methods Thereof
Substituted Tetrahydrocarbazole and Cyclopentanoindole Derivatives
Related Assignments
(10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 26, 1996
From: ABRAMOVITZ, MARK; ADAM, MOHAMMED; BASTIEN, LISON; GRYGORCZYK, RICHARD
To: MERCK FROSST CANADA, INC.
Reel/Frame 008106/0297 →
Re-Record to Add Assignor Name of a Previously Recorded Document.
Sep 6, 1996
From: BOIE, MARK ABRAMOVITZ; GRYGORDZYK, RICHARD; METTERS, KATHLEEN; RUSHMORE, THOMAS H.
To: MERCK FROSST CANADA, INC.
Reel/Frame 008120/0499 →
Change of Name
Oct 2, 2001
From: MERCK FROSST CANADA INCORPORATED
To: MERCK FROSST CANADA AND CO.
Reel/Frame 012232/0401 →
Assignment of Assignor's Interest
Jun 21, 2006
From: NICHOLSON, DONALD W.
To: MERCK FROSST CANADA, INC.
Reel/Frame 018002/0516 →
Change of Name
Jul 25, 2006
From: MERCK FROSST CANADA, INC.
To: MERCK FROSST CANADA AND COMPANY
Reel/Frame 017982/0426 →
License
Feb 22, 2007
From: MERCK FROSST CANADA, INC.
To: MILLENIA HOPE INC.
Reel/Frame 018917/0574 →
Confirmatory License
Jul 23, 2008
From: VANDERBILT UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021283/0422 →
Assignment of Assignor's Interest
Oct 1, 2009
From: MERCK FROSST CANADA LTD.; MERCK FROSST CANADA & CO.
To: MERCK SHARP & DOHME PHARMACEUTICALS, SRL.
Reel/Frame 023312/0589 →
Change of Name
Jan 27, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023852/0595 →
Confirmatory License
May 29, 2011
From: VANDERBILT UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026358/0112 →